NeuClone's superior CHO cell lines
NeuClone's production cell lines are vastly superior to their competitors' due to the company’s design and implementation of strategic processes in the generation of each recombinant CHO line.
Serum-free, chemically defined, animal origin free and protein free production.
From master cell banks of parental CHO cell stocks to final recombinant clonal isolates, NeuClone cells are cultured using chemically defined, protein-free media designed specifically for CHO cell growth and production. This facilitates purification and downstream processing and is less likely to contain adventitious agents due to the lack of animal-origin materials.
Growth of cells and production of recombinant proteins in suspension culture
NeuClone's production cell lines are derived and generated as suspension cultures designed for the high-yield production of recombinant proteins.
Fully traceable and documented lineage
NeuClone provides a fully traceable and documented history of the processes involved in the generation of each clonal line. Such documentation is critically important for regulatory approval of any protein therapeutic; thus NeuClone further distinguishes itself by implementing processes that exceed drug safety guidelines in the generation of industrial cell lines commencing with master and working cell banks of the parental stocks and maintaining good laboratory practice (GLP) throughout the production of recombinant lines. Master cell banks and master working cell banks are generated for each of NeuClone's final clones. Our procedures and documentation render each of our cell lines equivalent to a drug master file facilitating drug submission to regulatory authorities in international markets. In this way, NeuClone sets the highest industry standard in cell line development for commercial production of protein therapeutics in the generics market.
Process Development and Technology Transfer
NeuClone aims to provide superior CHO cell lines with exceptional growth and production characteristics. The company is relentless in its efforts to achieve the highest yields in its production cell lines without compromising growth and stability. NeuClone offers to its clients a process development program through media optimisation and a purification strategy ready for technology transfer to the client's facilities. Please contact us for your specific requirements.
